Fig. 4From: ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in CholangiocarcinomaRelationship between ACSL4 expression and TILs in CHOL. (A-B) Relative proportions of 22 subtypes of tumor-infiltrating immune cells for each sample in CHOL by CIBERSORT. (C) Comparison of the immune cell fraction difference between the low and high ACSL4 expression groupsBack to article page